MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway.

Area of Science:

• Molecular Biology
• Cell Signalling
• Cancer Research

Background:

• The Wnt/beta-catenin signalling pathway is crucial for cellular processes and is frequently dysregulated in cancer.
• Axin1 is a key scaffold protein in the beta-catenin destruction complex, essential for Wnt pathway regulation.
• Understanding how Wnt signalling modulates the destruction complex is vital for therapeutic development.

Purpose of the Study:

• To identify novel Axin1 binding partners involved in Wnt signalling regulation.
• To elucidate the mechanism by which Wnt signalling influences the beta-catenin destruction complex.
• To investigate the role of MAP3K1 in the canonical Wnt pathway.

Main Methods:

• Immunoprecipitation-coupled proteomics to identify Axin1 interactors.
• Confirmation of protein interactions in HEK293T and Ls174T cells.
• siRNA-mediated knockdown of MAP3K1.
• Analysis of TCF/LEF-driven transcription and Wnt target gene expression.
• Mutational analysis of MAP3K1 (ubiquitin ligase and kinase activity).

Main Results:

• Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) was identified as a novel Axin1 interactor.
• The Axin1-MAP3K1 interaction is induced and modulated by Wnt stimulation.
• MAP3K1 depletion abrogated Wnt target gene transcription in colorectal cancer cells.
• MAP3K1's E3 ubiquitin ligase activity, not its kinase activity, is essential for regulating Wnt/beta-catenin signalling.

Conclusions:

• MAP3K1 is a novel component of the canonical Wnt signalling pathway.
• MAP3K1 positively regulates Wnt target gene expression through its E3 ubiquitin ligase activity.
• This finding provides new insights into Wnt pathway regulation and potential therapeutic targets in cancer.